In this article I explore how experimental stem cell treatments have become a therapeutic
choice in India. Drawing on ethnographic fieldwork, I illustrate six sociotechnical pathways …

Over the last three to four years, an increasing number of private and public sector tertiary
level hospitals and research centres in India have been using stem cell therapy, especially …

Public engagement through government-sponsored “public consultations” in biomedical
innovation, specifically stem cell research and therapy, has been relatively limited in India …

Experimental stem cell therapy (ESCT) as a mode of therapeutic treatment is widely
available in India in spite of regulatory prohibition of such practice and little scientific …

This book takes as its point of departure a humble cell lying on the intersection of ideas as
diverse and yet interlaced as life, knowledge, commerce, governance, and ethics. It seeks to …

In this article, I explore the opinions of India's stem cell scientists on unproven and
unregulated stem cell treatment provision in the country's private health sector. Drawing on …

This article aims to put into perspective the binary opposition between 'scientific'clinical
research trials and 'rogue'experimental stem cell therapies, and to show why the ethics …

The book explores personal and professional multidisciplinary perspectives on stem cell
research and clinical application. The collection is organized around three interconnected …

This chapter draws on fieldwork undertaken in India on stem cells. The regulatory and
bioethical guidance framework in India, like the science driving stem cell innovations and …

Having discussed discourses around bioethics and stem cell research and notions of risk in
China and Japan in Chapters 5 and 6, this chapter focuses on the ways in which stem cell …